Kadmon Pharmaceuticals Signs Three Hepatitis C Deals
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 10 (Table of Contents)
Published: 13 Dec-2010
DOI: 10.3833/pdr.v2010.i10.1409 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Samuel Waksal, the ex-ImClone Systems CEO who served 5 years in prison for securities fraud, has made a comeback in the biotech arena with his new company, Kadmon Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS